Evidence map›Paper›PMID 40456763›Full record

ArticleScientific reports2025

GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer's rat model.

Ana Abril Vidal Escobedo, Facundo Peralta, Gustavo Ramón Morel, Martino Avallone, Tomas Björklund, Paula Cecilia Reggiani, Joaquín Pardo

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Abril Vidal Escobedo *Facultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata "Profesor Doctor Rodolfo R. Brenner", Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Facundo Peralta *Facultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata "Profesor Doctor Rodolfo R. Brenner", Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Gustavo Ramón MorelFacultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata "Profesor Doctor Rodolfo R. Brenner", Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Martino AvalloneMolecular Neuromodulation, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.
Tomas BjörklundMolecular Neuromodulation, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.
Paula Cecilia Reggiani *Facultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata "Profesor Doctor Rodolfo R. Brenner", Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Joaquín Pardo *Facultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata "Profesor Doctor Rodolfo R. Brenner", Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina. joaquin.pardo@med.lu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes are essential for maintaining neuronal health and regulating the brain's inflammatory environment. In this study, we developed an adeno-associated viral vector (AAV9) designed to selectively overexpress glial cell line-derived neurotrophic factor (GDNF) in astrocytes, using the astrocyte-specific GFAP promoter and TdTomato for transduction tracking. This approach yielded targeted GDNF expression in hippocampal astrocytes. Sholl analysis revealed that GDNF overexpression significantly enhanced astrocytic branching complexity and process length. Using the intracerebroventricular streptozotocin (STZ) model of neurodegeneration, we evaluated the impact of GDNF on astrocytic morphology, neuroinflammation, and hippocampal-dependent memory. Although GDNF prevented astrocytic process length reduction, it did not mitigate neuroinflammation, as evidenced by persistent microglial activation, nor did it improve deficits in the novel object recognition task. However, GDNF + STZ treated animals performed similarly as SHAM controls at exploring the goal sector at the Barnes Maze. These findings demonstrate the capacity of the AAV-GFAP-GDNF-TdTom construct to induce astrocytic branching and partially preserve memory function. They also underscore its partial therapeutic potential in a neuroinflammatory, metabolically compromised and neurodegenerative context.

Indexed as

Alzheimer DiseaseAstrocytesGlial Cell Line-Derived Neurotrophic FactorHippocampusAnimalsDependovirusDisease Models, AnimalMaleMemoryRatsRats, Sprague-DawleyStreptozocinGdnf protein, ratGlial Cell Line-Derived Neurotrophic FactorStreptozocinAAV9AstrocytesGDNFHippocampusNeurodegeneration

Identifiers

PMID40456763
PMCPMC12130339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.